Safety and efficacy of first-line bevacizumab (Bv) plus chemotherapy in elderly patients (pts) with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): SAiL (MO19390)

被引：4

作者：

Garrido, P. ^{[1
]}

Thatcher, N. ^{[2
]}

Crino, L. ^{[3
]}

Dansin, E. ^{[4
]}

Laskin, J. ^{[5
]}

Pavlakis, N. ^{[6
]}

Tsai, C. M. ^{[7
]}

Reck, M. ^{[8
]}

Schneider, C. P. ^{[9
]}

Griesinger, F. ^{[10
]}

机构：

[1] Hosp Ramon & Cajal, E-28034 Madrid, Spain

[2] Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England

[3] Perugia Gen Hosp, Perugia, Italy

[4] Ctr Oscar Lambret, F-59020 Lille, France

[5] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada

[6] Royal N Shore Hosp, Sydney, NSW, Australia

[7] Taipei Vet Gen Hosp, Taipei, Taiwan

[8] Krankenhaus Grosshansdorf, Grosshansdorf, Germany

[9] Cent Clin Bad Berka, Bad Berka, Germany

[10] Pius Hosp, Oldenburg, Germany

来源：

EJC SUPPLEMENTS | 2009年 / 7卷 / 02期

关键词：

D O I：

10.1016/S1359-6349(09)71883-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：557 / 557

页数：1